Angela Crouse, NP

NPI: 1306144704
Total Payments
$516.32
2024 Payments
$312.25
Companies
11
Transactions
15
Medicare Patients
2,118
Medicare Billing
$80,289

Payment Breakdown by Category

Food & Beverage$516.32 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $516.32 15 100.0%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $155.56 3 $0 (2024)
Medtronic, Inc. $138.55 1 $0 (2023)
Novartis Pharmaceuticals Corporation $79.43 3 $0 (2024)
Kestra Medical Technology Services, Inc. $24.57 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $22.08 1 $0 (2024)
Boston Scientific Corporation $20.26 1 $0 (2023)
Philips Electronics North America Corporation $17.68 1 $0 (2022)
Esperion Therapeutics, Inc. $15.90 1 $0 (2024)
CVRx, Inc. $14.71 1 $0 (2024)
Novo Nordisk Inc $14.04 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $312.25 10 Boehringer Ingelheim Pharmaceuticals, Inc. ($155.56)
2023 $186.39 4 Medtronic, Inc. ($138.55)
2022 $17.68 1 Philips Electronics North America Corporation ($17.68)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/31/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $15.90 General
Category: ANTILIPEMIC AGENTS
10/24/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $24.57 General
Category: Cardiology
10/16/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $26.97 General
Category: Cardiology/Vascular Diseases
10/07/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $14.71 General
Category: Heart Failure and Hypertension
10/02/2024 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $22.08 General
Category: Cardiovascular and Metabolism
07/24/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $112.89 General
Category: DIABETES
07/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $24.01 General
Category: DIABETES
06/25/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $23.96 General
Category: Cardiology/Vascular Diseases
05/01/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.66 General
Category: DIABETES
03/05/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $28.50 General
Category: Cardiology/Vascular Diseases
12/06/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $20.26 General
11/20/2023 Medtronic, Inc. COREVALVE EVOLUT R (Device) Food and Beverage In-kind items and services $138.55 General
Category: Transcatheter Valve Systems
08/25/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $13.54 General
Category: Inhibitor of SGLT2 and SGLT1
02/10/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $14.04 General
Category: Obesity
04/15/2022 Philips Electronics North America Corporation (2929) Philips Circuits (Device) Food and Beverage Cash or cash equivalent $17.68 General
Category: Medical Device

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 460 491 $49,764 $16,515
2022 4 509 575 $65,915 $23,976
2021 4 579 619 $62,939 $21,953
2020 6 570 604 $56,242 $17,845
Total Patients
2,118
Total Services
2,289
Medicare Billing
$80,289
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 122 142 $23,430 $10,782 46.0%
93016 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician Facility 2023 213 214 $16,050 $2,703 16.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 39 42 $4,704 $2,238 47.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 86 93 $5,580 $792.00 14.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 199 256 $42,240 $19,061 45.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 46 50 $5,600 $2,134 38.1%
93016 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician Facility 2022 129 129 $9,675 $1,626 16.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 135 140 $8,400 $1,155 13.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 145 172 $28,380 $13,535 47.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 71 77 $8,624 $4,091 47.4%
93016 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision Facility 2021 249 249 $18,675 $3,249 17.4%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 114 121 $7,260 $1,078 14.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 116 132 $20,450 $8,383 41.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 101 110 $11,645 $4,759 40.9%
93016 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision Facility 2020 216 217 $16,275 $2,873 17.7%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 105 110 $6,600 $1,091 16.5%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 17 20 $872.00 $535.78 61.4%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2020 15 15 $400.00 $203.13 50.8%

About Angela Crouse, NP

Angela Crouse, NP is a Nurse Practitioner healthcare provider based in Muncie, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1306144704.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Crouse, NP has received a total of $516.32 in payments from pharmaceutical and medical device companies, with $312.25 received in 2024. These payments were reported across 15 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($516.32).

As a Medicare-enrolled provider, Crouse has provided services to 2,118 Medicare beneficiaries, totaling 2,289 services with total Medicare billing of $80,289. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Muncie, IN
  • Active Since 03/09/2011
  • Last Updated 03/04/2021
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1306144704

Products in Payments

  • JARDIANCE (Drug) $155.56
  • COREVALVE EVOLUT R (Device) $138.55
  • LEQVIO (Drug) $50.93
  • ENTRESTO (Drug) $28.50
  • Assure WCD (Device) $24.57
  • BRILINTA (Drug) $22.08
  • (2929) Philips Circuits (Device) $17.68
  • NEXLETOL (Drug) $15.90
  • Barostim Neo System (Device) $14.71
  • Wegovy (Drug) $14.04
  • Inpefa (Drug) $13.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Muncie